As of Aug 31
| -0.03 / -0.08%|
The 29 analysts offering 12-month price forecasts for Fresenius Medical Care AG & Co KGaA have a median target of 42.06, with a high estimate of 50.82 and a low estimate of 32.00. The median estimate represents a +10.33% increase from the last price of 38.12.
The current consensus among 32 polled investment analysts is to Hold stock in Fresenius Medical Care AG & Co KGaA. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.